redsox just trying to learn so hope you will provide some thoughts as no attempt at controversy. Why such different views on technical successes between your observations and observations of:
petryandre33 • 5 hours ago
Yes, manipulation it is: June 23, 2015: Collaboration with Astra Zeneca results in second Accurin candidate to enter clinical deverlopment + BIND will earn a $4 million milestone payment upon first dosing a patient + PROMISING AZD2811 DATA, showing that it delivers PROLONGED EXPOSURE TO ACTIVE DRUG while having the potential to adapt the dosing regimen. In addition, using mass spectrometric imagi ng, AZD2811 WAS SHOWN TO ACCUMULATE IN TUMORS AND ACHIEVE PROLONGED TUMOR DRUG EXPOSURE. This represents THE FIRST TIME DISTRIBUTION OF NANOPARTICLES IN TUMORS HAS BEEN DEMONSTRATED!!! + minimizing the bone marrow toxicity and so on, and so on en what does the PPS: down, down, down from $6,22 to $5,68. Comparing with the news of Monday, April 6, 2015: BIND Extends Collaboration with Pfizer to Develop Accurins: a few days later PPS was up (April 15, 2015) to $8,10.
So in a few months PPS is down from $8,10 to $5,68 after nothing than good news (see also the NAVB collaboration)... It's becoming a strange world... maybe a company(s) wanting to take-over BIND at the very cheap (hostile take-over)... medicinal nanoengineering is the future and BIND's technology platform is worth $billions...
eesp and hughes (also peek, billy and other constructive thinkers) why not just take your scientific knowledge and discussion to the investor village navb board site where you can share your scientific/researched views, etc. It is free to join and you can use web site links, private messaging, etc.
during 1st quarter 2015
Goldman raised their share investment by 3.123 mm shares, UBS by .944 mm shares and Vanguard by .303 mm shares
Vanguard to 4.5 mm shares, Goldman to 3.2 mm shares and UBS to 1.6 mm shares
my experience is these are very ethical people and when the say things they believe it and live it
"..And as a reminder, the DCP enterprise has a long history, approximately 90 years, of prudently managing through low commodity environments. We're well underway on tightening our belts with a strategic focus on prudently managing the DCP enterprise to be an even fitter and stronger company."
See SE CC today-starts off with a very good recap but will still be sometime between now and Oct.-Yahoo will not let me post it . Also at end of P66 CC less referenced P66 indicated it would probably not be a equity offering of DCP.
more details on mlp or bry iv boards-yahoo will not let me post under moneyonomics for some reason